Skip to main content

Prognostic Significance of Fibroblast Growth Factor Receptor 3 (FGFR-3) Overexpression in Invasive Mammary Carcinoma (BRCA)

Publication ,  Conference
Al-Rohil, RN; Presta, MJ; Kallakury, BVS; Sheehan, GM; Sheehan, CE; Boguniewicz, AB; Ross, JS
Published in: LABORATORY INVESTIGATION
February 1, 2013

Duke Scholars

Published In

LABORATORY INVESTIGATION

ISSN

0023-6837

Publication Date

February 1, 2013

Volume

93

Start / End Page

26A / 27A

Location

Baltimore, MD

Publisher

NATURE PUBLISHING GROUP

Conference Name

102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)

Related Subject Headings

  • Pathology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Al-Rohil, R. N., Presta, M. J., Kallakury, B. V. S., Sheehan, G. M., Sheehan, C. E., Boguniewicz, A. B., & Ross, J. S. (2013). Prognostic Significance of Fibroblast Growth Factor Receptor 3 (FGFR-3) Overexpression in Invasive Mammary Carcinoma (BRCA). In LABORATORY INVESTIGATION (Vol. 93, pp. 26A-27A). Baltimore, MD: NATURE PUBLISHING GROUP.
Al-Rohil, R. N., M. J. Presta, B. V. S. Kallakury, G. M. Sheehan, C. E. Sheehan, A. B. Boguniewicz, and J. S. Ross. “Prognostic Significance of Fibroblast Growth Factor Receptor 3 (FGFR-3) Overexpression in Invasive Mammary Carcinoma (BRCA).” In LABORATORY INVESTIGATION, 93:26A-27A. NATURE PUBLISHING GROUP, 2013.
Al-Rohil RN, Presta MJ, Kallakury BVS, Sheehan GM, Sheehan CE, Boguniewicz AB, et al. Prognostic Significance of Fibroblast Growth Factor Receptor 3 (FGFR-3) Overexpression in Invasive Mammary Carcinoma (BRCA). In: LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2013. p. 26A-27A.
Al-Rohil, R. N., et al. “Prognostic Significance of Fibroblast Growth Factor Receptor 3 (FGFR-3) Overexpression in Invasive Mammary Carcinoma (BRCA).” LABORATORY INVESTIGATION, vol. 93, NATURE PUBLISHING GROUP, 2013, pp. 26A-27A.
Al-Rohil RN, Presta MJ, Kallakury BVS, Sheehan GM, Sheehan CE, Boguniewicz AB, Ross JS. Prognostic Significance of Fibroblast Growth Factor Receptor 3 (FGFR-3) Overexpression in Invasive Mammary Carcinoma (BRCA). LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2013. p. 26A-27A.

Published In

LABORATORY INVESTIGATION

ISSN

0023-6837

Publication Date

February 1, 2013

Volume

93

Start / End Page

26A / 27A

Location

Baltimore, MD

Publisher

NATURE PUBLISHING GROUP

Conference Name

102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)

Related Subject Headings

  • Pathology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences